Market OverviewThe global Epilepsy Drugs Market is valued at USD 10.63 billion in 2024 and is projected to reach a value ...

DelveInsight's Epilepsy pipeline report depicts a robust space with 75+ active players working to develop 90+ pipeline ...

Conditions like dementia, migraines and epilepsy are all too common, but many neurological patients in Scotland struggle to ...

Scientists at ETH Zurich have broken new ground by generating over 400 types of nerve cells from stem cells in the lab, far ...

Almost everyone has been touched by, or knows someone, with epilepsy. This complex, serious neurological disorder affects nearly 3 million adults in the U.S., or around 1% of the population ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...

Epilepsy is a neurological disorder characterized by recurrent seizures, affecting millions of individuals worldwide. This ...

The global Brain Pacemaker Market represents a rapidly expanding segment of the medical device industry, valued at USD 3.66 ...

Pediatric epilepsy is a complex and heterogeneous neurological disorder characterized by recurrent seizures due to abnormal ...

Nerve cells are not just nerve cells. Depending on how finely we distinguish, there are several hundred to several thousand ...

This story was authored by Ansley Kelm, of University Hospitals. Epilepsy is among the most common neurological conditions, marked by unpredictable seizures, accidents and injuries, reduced quality of ...

A growing body of neuroscience research indicates how precision medicine can drive more efficient, targeted, and equitable healthcare delivery. A recent medical publication on HCN channelopathies in ...